Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 18 citations in OpenAlex.
Alicia BedollaDepartment of Molecular and Cellular Biosciences, University of Cincinnati, Cincinnati, OH 45229, USA.
Gabriel MckinseyDepartment of Pediatrics, University of California San Francisco, San Francisco, CA 94143, USA.
Kierra WareDepartment of Molecular and Cellular Biosciences, University of Cincinnati, Cincinnati, OH 45229, USA.
Nicolas SantanderInstituto de Ciencias de la Salud, Universidad de O´Higgins, Rancagua, Chile.
Thomas ArnoldDepartment of Pediatrics, University of California San Francisco, San Francisco, CA 94143, USA.
Yu LuoDepartment of Molecular and Cellular Biosciences, University of Cincinnati, Cincinnati, OH 45229, USA.
University of Cincinnati · USUniversity of California, San Francisco · USUniversity of O'Higgins · CL
Funding
Defective heme transport in the development of congenital hydrocephalusR01NS123168 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ARNOLD, THOMAS DARMODY · 2021 to 2025
$3.1M
How do CNS fibroblasts regulate the response to neuroinflammation?R01NS119615 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DANEMAN, RICHARD · 2021 to 2025
$2.4M
Modulating a critical inhibitory proteoglycan receptor to promote functional recovery after strokeR01NS107365 · NINDS · UNIVERSITY OF CINCINNATI · PI LUO, YU, SILVER, JERRY · 2019 to 2022
$1.4M
Leica Stellaris 8 Confocal MicroscopeS10OD030402 · OD · UNIVERSITY OF CINCINNATI · PI HONG, CHRISTIAN I · 2021 to 2021
$598k
Ablating choroid plexus epithelial cells in the developing mouse brain: A new tool to approach CSF disordersR21NS127177 · NINDS · UNIVERSITY OF CINCINNATI · PI GOTO, JUNE, LUO, YU · 2022 to 2022
$457k
A Dual Role of Activin-like kinase 5 (ALK5)-mediated TGF Beta Signaling in Adult NeurogenesisF31NS129204 · NINDS · UNIVERSITY OF CINCINNATI · PI WARE, KIERRA · 2023 to 2025
$83k
The Role of Activin-like kinase 5 (ALK5) for maintaining microglia and astrocyte homeostasis and activationF31NS125930 · NINDS · UNIVERSITY OF CINCINNATI · PI BEDOLLA, ALICIA MARIE · 2022 to 2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Finding the right tool: a comprehensive evaluation of microglial inducible cre mouse models. · full record | OpenQuestion